Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Impax’s Generic Amrix Must Stay Banned: Cephalon, Mylan
Dec. 14, 2011
Cephalon and Mylan fired back at Impax Laboratories’ bid to have itself excluded from an injunction barring generic versions of Cephalon’s muscle relaxant Amrix, saying Impax is seeking an improper “do-over” of the decision.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing